Hyperion Therapeutics Issued Key Patent Pertaining to Use of Fasting Ammonia

Hyperion Therapeutics Issued Key Patent Pertaining to Use of Fasting Ammonia

[at noodls] – SOUTH SAN FRANCISCO, Calif., April 16, 2013 (GLOBE NEWSWIRE) — Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the U.S. Patent & Trademark Office (USPTO) has issued to Hyperion U.S. patent … more

View todays social media effects on HPTX

View the latest stocks trending across Twitter. Click to view dashboard

See who Hyperion is hiring next, click here to view

Share this post